You are here: Industry Insights > Propanc Biopharma

News List

Australia's Propanc Biopharma gets US Patent biospectrumasia
August 25, 2019
Propanc Biopharma Receives Granted US Patent Covering Additional Composition Claims for PRP.
Propanc Biopharma Granted US Patent Covering Additional Composition Claims for PRP americanpharmaceuticalreview
August 23, 2019
Propanc Biopharma, Inc. has received a granted US patent from the United States Patent and Trademark Office (USPTO) covering composition of matter claims involving trypsinogen and chymotrypsinogen.
Propanc Biopharma Commences Drug Discovery Research Collaboration pharmafocusasia
January 04, 2019
Propanc Biopharma, Inc., a clinical stage biopharmaceutical company focused on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic.....
Propanc Biopharma Enters into Research Collaboration Agreement with the University of Jaén pharmafocusasia
September 21, 2018
Propanc Biopharma, Inc., a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers, today announced the executio
Propanc Biopharma Completes Reproduction run for its pancreatic drug biospectrumasia
March 16, 2018
The Company's initial target patient populations are pancreatic, ovarian and colorectal cancers, representing an estimated combined market segment of $14 billion in 2020